311 related articles for article (PubMed ID: 38191692)
1. The Changes of Blood and CSF Ion Levels in Depressed Patients: a Systematic Review and Meta-analysis.
Meng Y; Liu S; Yu M; Liang H; Tong Y; Song J; Shi J; Cai W; Wu Q; Wen Z; Wang J; Guo F
Mol Neurobiol; 2024 Jan; ():. PubMed ID: 38191692
[TBL] [Abstract][Full Text] [Related]
2. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability.
Anderson IM
Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346
[TBL] [Abstract][Full Text] [Related]
3. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability.
Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P
Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011
[TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patients.
Qiu BY; Qiao JX; Yong J
Iran J Pharm Res; 2014; 13(4):1213-9. PubMed ID: 25587309
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
7. The changes of serum zinc, copper, and selenium levels in epileptic patients: a systematic review and meta-analysis.
Jia W; Song Y; Yang L; Kong J; Boczek T; He Z; Wang Y; Zhang X; Hu H; Shao D; Tang H; Xia L; Xu X; Guo F
Expert Rev Clin Pharmacol; 2020 Sep; 13(9):1047-1058. PubMed ID: 32856976
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Traditional Chinese Medicine Combined with Selective Serotonin Reuptake Inhibitors on the Treatment for Parkinson's Disease with Depression: A Systematic Review and Meta-Analysis.
Feng ST; Wang XL; Wang YT; Yuan YH; Li ZP; Chen NH; Wang ZZ; Zhang Y
Am J Chin Med; 2021; 49(3):627-643. PubMed ID: 33657988
[TBL] [Abstract][Full Text] [Related]
9. Status and potential diagnostic roles of essential trace elements in Kashin- Beck disease patients.
Fu G; Chen X; Qi M; Du X; Xia Z; Liu Q; Sun N; Shi C; Zhang R
J Trace Elem Med Biol; 2022 Jan; 69():126880. PubMed ID: 34717166
[TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
Anderson IM
J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis.
Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062
[TBL] [Abstract][Full Text] [Related]
12. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients.
Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML
Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants.
Perry PJ
J Affect Disord; 1996 Jun; 39(1):1-6. PubMed ID: 8835647
[TBL] [Abstract][Full Text] [Related]
14. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis.
Wilson K; Mottram P
Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699
[TBL] [Abstract][Full Text] [Related]
15. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Montgomery SA; Judge R
Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
[TBL] [Abstract][Full Text] [Related]
16. Depression and pain: an appraisal of cost effectiveness and cost utility of antidepressants.
Pan YJ; Pan CH; Chan HY; Kuo KH
J Psychiatr Res; 2015 Apr; 63():123-31. PubMed ID: 25727051
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
Undurraga J; Baldessarini RJ
J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600
[TBL] [Abstract][Full Text] [Related]
18. Preventive Effects of Lithium Carbonate on Antidepressant-Induced Switch During Depressive Episodes: Chinese Data Analysis.
Wangqiang L; Hejian T; Fengli S; Weidong J
Altern Ther Health Med; 2022 Jan; 28(1):58-64. PubMed ID: 34559689
[TBL] [Abstract][Full Text] [Related]
19. [Fluoxetine: an update of its use in major depressive disorder in adults].
Gourion D; Perrin E; Quintin P
Encephale; 2004; 30(4):392-9. PubMed ID: 15597466
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors.
Peretti S; Judge R; Hindmarch I
Acta Psychiatr Scand Suppl; 2000; 403():17-25. PubMed ID: 11019931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
